Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Pharmacopsychiatry

Retrieve available abstracts of 16 articles:
HTML format

Single Articles

    May 2024
  1. KOMATSU Y, Takehara M, Hart X, Takahashi Y, et al
    Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments.
    Pharmacopsychiatry. 2024 May 6. doi: 10.1055/a-2307-6484.
    PubMed     Abstract available

    April 2024
  2. LLORCA-BOFI V, Bioque M, Madero S, Mallorqui A, et al
    Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naive, Schizophrenia-Spectrum Disorder.
    Pharmacopsychiatry. 2024 Apr 15. doi: 10.1055/a-2290-6386.
    PubMed     Abstract available

    February 2024
  3. HART XM, Mitsukura Y, Bies RR, Uchida H, et al
    Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis.
    Pharmacopsychiatry. 2024 Feb 22. doi: 10.1055/a-2258-0379.
    PubMed     Abstract available

    January 2024
  4. BREIT S, Meyer A, Schmitt W, Bracht T, et al
    The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response.
    Pharmacopsychiatry. 2024;57:13-20.
    PubMed     Abstract available

    July 2023
  5. WAGNER E, Strube W, Gorlitz T, Aksar A, et al
    Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial.
    Pharmacopsychiatry. 2023 Jul 28. doi: 10.1055/a-2110-4259.
    PubMed     Abstract available

    May 2023

  6. [Not Available].
    Pharmacopsychiatry. 2023;56:127.

    March 2023
  7. SPOOV J
    The Mini-TRH Test.
    Pharmacopsychiatry. 2023;56:51-56.
    PubMed     Abstract available

  8. BARTSCH JC, Schott BH, Behr J
    Hippocampal Dysfunction in Schizophrenia and Aberrant Hippocampal Synaptic Plasticity in Rodent Model Psychosis: a Selective Review.
    Pharmacopsychiatry. 2023;56:57-63.
    PubMed     Abstract available

    November 2022
  9. AGUGLIA A, Fusar-Poli L, Natale A, Amerio A, et al
    Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study.
    Pharmacopsychiatry. 2022;55:281-289.
    PubMed     Abstract available

    July 2022
    The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms.
    Pharmacopsychiatry. 2022 Jul 11. doi: 10.1055/a-1882-6802.

  11. KISHI T, Sakuma K, Iwata N
    Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis.
    Pharmacopsychiatry. 2022 Jul 5. doi: 10.1055/a-1860-2793.
    PubMed     Abstract available

  12. LOPEZ-MORINIGO JD, Leucht S, Arango C
    Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
    Pharmacopsychiatry. 2022 Jul 1. doi: 10.1055/a-1854-0185.
    PubMed     Abstract available

    June 2022
  13. ESEN-SEHIR D, Kopf J, Hagele S, Plichta MM, et al
    Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Pharmacopsychiatry. 2022 Jun 22. doi: 10.1055/a-1811-7241.
    PubMed     Abstract available

    May 2022
  14. MIURA G, Tanaka K, Kemuriyama T, Misawa F, et al
    Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review.
    Pharmacopsychiatry. 2022 May 5. doi: 10.1055/a-1811-7318.
    PubMed     Abstract available

    January 2022
  15. VEERMAN SRT, Bogers JPAM, Cohen D, Schulte PFJ, et al
    COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.
    Pharmacopsychiatry. 2022;55:48-56.
    PubMed     Abstract available

    May 2021
  16. SPOOV J, Bredbacka PE
    Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 microg i.v. TRH.
    Pharmacopsychiatry. 2021 May 12. doi: 10.1055/a-1481-9058.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.